{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urological-cancers-recognition-referral/diagnosis/symptoms-suggestive-of-urological-cancers/","result":{"pageContext":{"chapter":{"id":"57be949e-d544-560a-b03e-2211a2434d97","slug":"symptoms-suggestive-of-urological-cancers","fullItemName":"Symptoms suggestive of urological cancers","depth":2,"htmlHeader":"<!-- begin field 7fa0e66a-3cae-40cd-b347-ce3db1d0a3bc --><h2>Symptoms suggestive of urological cancers</h2><!-- end field 7fa0e66a-3cae-40cd-b347-ce3db1d0a3bc -->","summary":"","htmlStringContent":"<!-- begin item fd68247b-ceb0-4cf0-ae58-2a79f0538ab2 --><!-- begin field b2b6f04a-ee50-43b3-a77c-f9bd6ef976b2 --><p><strong>Table 2</strong><strong>. </strong>Symptoms suggestive of urological cancers.</p><table data-table-id=\"67e77759-5f7a-40c8-800d-acce014ccf15\"><thead><tr><th><p>Symptom</p></th><th><p>Possible cancer</p></th><th><p>Referral recommendation</p></th></tr></thead><tbody><tr><td>Appetite loss (unexplained)</td><td>Several, including lung, oesophageal, stomach, colorectal, pancreatic, bladder, or renal</td><td><p>Carry out an assessment for additional symptoms, signs, or findings that may help to clarify which cancer is most likely</p><p>Offer urgent investigation or a suspected cancer pathway referral (for an appointment within 2 weeks)</p></td></tr><tr><td>Weight loss (unexplained)</td><td>Several, including colorectal, gastro-oesophageal, lung, prostate, pancreatic, or urological cancer</td><td><p>Carry out an assessment for additional symptoms, signs, or findings that may help to clarify which cancer is most likely</p><p>Offer urgent investigation or a suspected cancer pathway referral (for an appointment within 2 weeks)</p></td></tr><tr><td>Deep vein thrombosis</td><td>Several, including urogenital, breast, colorectal, or lung</td><td><p>Carry out an assessment for additional symptoms, signs, or findings that may help to clarify which cancer is most likely</p><p>Consider urgent investigation or a suspected cancer pathway referral (for an appointment within 2 weeks)</p></td></tr><tr><td>Dysuria with unexplained non-visible haematuria, age 60 years and over</td><td>Bladder</td><td>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Haematuria (visible and unexplained) either without urinary tract infection or that persists or recurs after successful treatment of urinary tract infection, age 45 years and over</td><td>Bladder or renal</td><td>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Haematuria (non-visible and unexplained) with dysuria or raised white cell count on a blood test, age 60 years and over</td><td>Bladder</td><td>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Urinary tract infection (unexplained and recurrent or persistent), age 60 years and over</td><td>Bladder</td><td>Consider non-urgent referral for bladder cancer in people aged 60 years and over with recurrent or persistent unexplained urinary tract infection</td></tr><tr><td>White cell count raised on a blood test with unexplained non-visible haematuria, age 60 years and over</td><td>Bladder</td><td>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Penile lesion (ulcerated and sexually transmitted infection has been excluded or persistent after treatment for a sexually transmitted infection has been completed) in men</td><td>Penile</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Penile mass (and sexually transmitted infection has been excluded as a cause) in men</td><td>Penile</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Penile symptoms affecting the foreskin or glans (unexplained or persistent) in men</td><td>Penile</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Erectile dysfunction in men</td><td>Prostate</td><td>Consider a prostate-specific antigen (PSA) test and digital rectal examination</td></tr><tr><td>Haematuria (visible) in men</td><td>Prostate</td><td>Consider a prostate-specific antigen (PSA) test and digital rectal examination</td></tr><tr><td>Lower urinary tract symptoms, such as nocturia, urinary frequency, hesitancy, urgency, or retention, in men</td><td>Prostate</td><td>Consider a prostate-specific antigen (PSA) test and digital rectal examination</td></tr><tr><td>Prostate feels malignant on digital rectal examination in men</td><td>Prostate</td><td>Refer men using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Prostate-specific antigen levels above the age-specific reference range</td><td>Prostate</td><td>Refer men using a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Testis enlargement or change in shape or texture (non-painful) in men</td><td>Testicular</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks)</td></tr><tr><td>Testicular symptoms (unexplained or persistent) in men</td><td>Testicular</td><td>Consider a direct access ultrasound scan</td></tr><tr><td colspan=\"3\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>]</td></tr></tbody></table><!-- end field b2b6f04a-ee50-43b3-a77c-f9bd6ef976b2 --><!-- end item fd68247b-ceb0-4cf0-ae58-2a79f0538ab2 -->","topic":{"id":"c64ec72d-4714-555b-b12a-fd441ca67b32","topicId":"4ccc54cd-a2c6-4fd3-9483-7b55de4e06fa","topicName":"Urological cancers - recognition and referral","slug":"urological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"a6bb987a-e632-5fc3-8d30-fb871a028ed1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"748a62ad-5b04-5468-a5ce-97c6481c7566","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"18d46e59-36c7-5b55-aa65-3600c901940f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a4e597f1-cc63-5d3b-97b7-ed0c1cbb2b37","slug":"changes","fullItemName":"Changes"},{"id":"969bbc1b-89ab-597b-9c13-e58c73973c47","slug":"update","fullItemName":"Update"}]},{"id":"2b375e17-1588-5dbc-bd02-bb06db6b34ff","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a969ea4e-5b1e-5ce3-bc10-facb662797f9","slug":"goals","fullItemName":"Goals"},{"id":"dd20c78a-fc7f-5f9c-a882-115907b19165","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9561691a-2035-5b37-9e9e-4f2930856afa","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"39713e7a-6ade-5468-a916-ef42fb466e19","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"559f945f-9805-56d3-b5eb-907dd06c68ab","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f90e5ce7-fddd-5929-994b-81f3568808c0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d68f575b-7060-52ac-8397-7dadfd612178","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"09cdbe97-79a1-5fd5-b0ef-8ca162bc3cba","slug":"presentation","fullItemName":"Presentation"},{"id":"0aebe8af-5f71-5805-b567-6d95c95ee05b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"6141fbed-d327-5e18-970c-951c38a9bfab","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f05bba22-10c0-58ff-9c5e-eb8128e76aa3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"57be949e-d544-560a-b03e-2211a2434d97","slug":"symptoms-suggestive-of-urological-cancers","fullItemName":"Symptoms suggestive of urological cancers"}]},{"id":"3b871537-9b9d-5b6f-a750-e314b06f2660","fullItemName":"Management","slug":"management","subChapters":[{"id":"bcec9d33-8447-5aa1-8b94-9ed03208f8f7","slug":"referral-for-suspected-urological-cancer","fullItemName":"Scenario: Referral for suspected urological cancer"}]},{"id":"f07308a4-4a9f-55e5-8994-88375e0358ff","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4ea550c2-d5c5-5e7c-86f1-51e4d7508e56","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bf6e9a70-8a4c-5aa5-9951-1b82bb2b47f1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0c4e1071-9827-57a2-bd0b-d69f2f249539","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1974a788-5c91-5701-ad92-0ccfd3d277ff","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2fd10533-9dfe-597b-937c-9ab7aff2a1d8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5d9c3f4e-c903-581a-b904-6ff63017d472","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c6ee8bcb-de73-5436-b699-cc8bb3dbaee2","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f05bba22-10c0-58ff-9c5e-eb8128e76aa3","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"63ad0d43-59a1-5b5d-a30d-e92a22d6b5bd","slug":"basis-for-recommendation-59b","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field e6a40133-82e0-4a95-8560-732540385d36 --><h3>Basis for recommendation</h3><!-- end field e6a40133-82e0-4a95-8560-732540385d36 -->","summary":null,"htmlStringContent":"<!-- begin item 59b227d1-1da0-4e3a-8804-8339ae412d9f --><!-- begin field 6c192afc-2905-4b65-adda-ecb03f7e6c12 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 6c192afc-2905-4b65-adda-ecb03f7e6c12 --><!-- end item 59b227d1-1da0-4e3a-8804-8339ae412d9f -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}